Colony-stimulating factor-1 signaling suppresses renal crystal formation

Journal of the American Society of Nephrology

Volumn 25, Issue 8, 2014, Pages 1680-1697

  Taguchi, Kazumi ^a   Okada, Atsushi ^a   Kitamura, Hiroshi ^a   Yasui, Takahiro ^a   Naiki, Taku ^a   Hamamoto, Shuzo ^a   Ando, Ryosuke ^a   Mizuno, Kentaro ^a   Kawai, Noriyasu ^a   Tozawa, Keiichi ^a   Asano, Kenichi ^b   Tanaka, Masato ^b   Miyoshi, Ichiro ^a   Kohri, Kenjiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; COLONY STIMULATING FACTOR 1; HERMES ANTIGEN; LIPOCORTIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; WHEWELLITE; DIFFERENTIATION ANTIGEN; MESSENGER RNA; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM OXALATE STONE; FLOW CYTOMETRY; GENE EXPRESSION; GENOTYPE; HYPEROXALURIA; KIDNEY TUBULE CELL; MOUSE; NEPHROLITHIASIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; ANIMAL; CULTURE TECHNIQUE; GENETICS; KIDNEY CALCULI; MACROPHAGE; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANNEXIN A2; ANTIGENS, CD44; ANTIGENS, DIFFERENTIATION; CALCIUM OXALATE; CELL CULTURE TECHNIQUES; CHEMOKINE CCL2; HYPEROXALURIA; KIDNEY CALCULI; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MALE; MICE; OSTEOPONTIN; PHAGOCYTOSIS; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84921686119     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013060675     Document Type: Article

References (66)

1. Okada A, Yasui T, Hamamoto S, Hirose M, Kubota Y, Itoh Y, Tozawa K, Hayashi Y, Kohri K: Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: Detection of stone-preventive factors and involvement of macrophage activity. J Bone Miner Res 24: 908-924, 2009
2. Okada A, Yasui T, Fujii Y,Niimi K,Hamamoto S, HiroseM, Kojima Y, Itoh Y, Tozawa K, Hayashi Y, Kohri K: Renal macrophage migration and crystal phagocytosis via inflammatory-related gene expression during kidney stone formation and elimination in mice: Detection by association analysis of stone-related gene expression and microstructural observation. J Bone Miner Res 25: 2701-2711, 2010
3. deWater R, Noordermeer C, van der Kwast TH, Nizze H, Boevé ER, Kok DJ, Schröder FH: Calcium oxalate nephrolithiasis: Effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 33: 761-771, 1999
4. Umekawa T, Chegini N, Khan SR: Oxalate ions and calcium oxalate crystals stimulateMCP-1 expression by renal epithelial cells. Kidney Int 61: 105-112, 2002
5. Grover PK, Thurgood LA, Fleming DE, van Bronswijk W, Wang T, Ryall RL: Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured renal cells. Am J Physiol Renal Physiol 294: F355-F361, 2008
6. Vervaet BA, Verhulst A, Dauwe SE, De Broe ME, D'Haese PC: An active renal crystal clearancemechanism in rat and man. Kidney Int 75: 41-51, 2009
7. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 3: 23-35, 2003
8. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686, 2004
9. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, KramerM, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R, Ottenhoff TH: Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 101: 4560-4565, 2004
10. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH: Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol 79: 285-293, 2006
11. van der Wal AC, Das PK, Tigges AJ, Becker AE: Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans. Am J Pathol 141: 161-168, 1992
12. Woollard KJ, Geissmann F: Monocytes in atherosclerosis: Subsets and functions. Nat Rev Cardiol 7: 77-86, 2010
13. Yasui T, Itoh Y, Bing G,Okada A, Tozawa K, Kohri K: Aortic calcification in urolithiasis patients. Scand J Urol Nephrol 41: 419-421, 2007
14. Reiner AP, Kahn A, Eisner BH, Pletcher MJ, Sadetsky N,WilliamsOD, Polak JF, Jacobs DR Jr., Stoller ML: Kidney stones and subclinical atherosclerosis in young adults: The CARDIA study. J Urol 185: 920-925, 2011
15. Khallou-Laschet J, Varthaman A, Fornasa G, Compain C, Gaston AT, ClementM,Dussiot M, LevillainO,Graff-Dubois S,Nicoletti A, Caligiuri G: Macrophage plasticity in experimental atherosclerosis. PLoS One 5: e8852, 2010
16. Fujita E, Shimizu A, Masuda Y, Kuwahara N, Arai T, Nagasaka S, Aki K, Mii A, Natori Y, Iino Y, Katayama Y, Fukuda Y: Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages. Am J Pathol 177: 1143-1154, 2010
17. Lee S,Huen S, NishioH, Nishio S, LeeHK, Choi BS, RuhrbergC, Cantley LG: Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22: 317-326, 2011
18. Zhang MZ, Yao B, Yang S, Jiang L, Wang S, Fan X, Yin H, Wong K, Miyazawa T, Chen J, Chang I, Singh A, Harris RC: CSF-1 signaling mediates recovery from acute kidney injury. J Clin Invest 122: 4519-4532, 2012
19. Alikhan MA, Jones CV, Williams TM, Beckhouse AG, Fletcher AL, Kett MM, Sakkal S, Samuel CS, Ramsay RG, Deane JA, Wells CA, Little MH, Hume DA, Ricardo SD: Colony-stimulating factor-1 promotes kidney growth and repair via alteration ofmacrophage responses. AmJ Pathol 179: 1243-1256, 2011
20. Menke J, Iwata Y, Rabacal WA, Basu R, Yeung YG, Humphreys BD, Wada T, Schwarting A, Stanley ER, Kelley VR: CSF-1 signals directly to renal tubular epithelial cells to mediate repair inmice.JClin Invest 119: 2330-2342, 2009
21. Qiao JH, Tripathi J, Mishra NK, Cai Y, Tripathi S, Wang XP, Imes S, Fishbein MC, Clinton SK, Libby P, Lusis AJ, Rajavashisth TB: Role of macrophage colony-stimulating factor in atherosclerosis: Studies of osteopetrotic mice. Am J Pathol 150: 1687-1699, 1997
22. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr., Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER: Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A 87: 4828-4832, 1990
23. Cecchini MG, Dominguez MG, Mocci S, Wetterwald A, Felix R, Fleisch H, Chisholm O, Hofstetter W, Pollard JW, Stanley ER: Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 120: 1357-1372, 1994
24. Yoshida H, Hayashi S, Kunisada T, OgawaM, Nishikawa S, Okamura H, Sudo T, Shultz LD,Nishikawa S: Themurinemutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444, 1990
25. Okada A,Nomura S,Higashibata Y, HiroseM,Gao B, YoshimuraM, Itoh Y, Yasui T, Tozawa K, Kohri K: Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection. Urol Res 35: 89-99, 2007
26. Khan SR, Glenton PA, Byer KJ: Modeling of hyperoxaluric calcium oxalate nephrolithiasis: Experimental induction of hyperoxaluria by hydroxy-L-proline. Kidney Int 70: 914-923, 2006
27. Khan SR, Canales BK:Genetic basis of renal cellular dysfunction and the formation of kidney stones. Urol Res 37: 169-180, 2009
28. Coe FL, Evan AP, Worcester EM, Lingeman JE: Three pathways for human kidney stone formation. Urol Res 38: 147-160, 2010
29. Evan A, Lingeman J, Coe FL, Worcester E: Randall's plaque: Pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69: 1313-1318, 2006
30. Miller NL, Gillen DL, Williams JC Jr., Evan AP, Bledsoe SB, Coe FL, Worcester EM, Matlaga BR, Munch LC, Lingeman JE: A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int 103: 966-971, 2009
31. Khan SR: Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones. Scanning Microsc 9: 89-100, 1995
32. Asselman M, Verhulst A, De Broe ME, Verkoelen CF: Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol 14: 3155-3166, 2003
33. Kumar V, FarellG, Deganello S, Lieske JC: Annexin II is present on renal epithelial cells and binds calcium oxalate monohydrate crystals. J Am Soc Nephrol 14: 289-297, 2003
34. Verhulst A, AsselmanM, De Naeyer S, Vervaet BA,MengelM, Gwinner W, D'Haese PC, Verkoelen CF, De Broe ME: Preconditioning of the distal tubular epitheliumof the human kidney precedes nephrocalcinosis. Kidney Int 68: 1643-1647, 2005
35. Vervaet BA, Verhulst A, De Broe ME, D'Haese PC: The tubular epithelium in the initiation and course of intratubular nephrocalcinosis. Urol Res 38: 249-256, 2010
36. Koul S, Khandrika L, Meacham RB, Koul HK: Genome wide analysis of differentially expressed genes in HK-2 cells, a line of human kidney epithelial cells in response to oxalate. PLoS One 7: e43886, 2012
37. Koul HK, Koul S, Fu S, Santosham V, Seikhon A, Menon M: Oxalate: From crystal formation to crystal retention. J AmSoc Nephrol 10[Suppl 14]: S417-S421, 1999
38. Kohri K, Suzuki Y, Yoshida K, Yamamoto K, Amasaki N, Yamate T, Umekawa T, Iguchi M, Sinohara H, Kurita T: Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. Biochem Biophys Res Commun 184: 859-864, 1992
39. Umekawa T, Yamate T, Amasaki N, Kohri K, Kurita T: Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure. Urol Int 55: 6-10, 1995
40. Okada A, Nomura S, Saeki Y, Higashibata Y, Hamamoto S, Hirose M, Itoh Y, Yasui T, Tozawa K, Kohri K:Morphological conversion of calcium oxalate crystals into stones is regulated by osteopontin in mouse kidney. J Bone Miner Res 23: 1629-1637, 2008
41. Hamamoto S, Nomura S, Yasui T,Okada A, HiroseM, Shimizu H, Itoh Y, Tozawa K, Kohri K: Effects of impaired functional domains of osteopontin on renal crystal formation: Analyses ofOPNtransgenic andOPN knockout mice. J Bone Miner Res 25: 2712-2723, 2010
42. Vachon E,Martin R, PlumbJ, Kwok V, Vandivier RW,GlogauerM, Kapus A, Wang X, Chow CW, Grinstein S, Downey GP: CD44 is a phagocytic receptor. Blood 107: 4149-4158, 2006
43. Marcondes MC, Poling M, Watry DD, Hall D, Fox HS: In vivo osteopontin-induced macrophage accumulation is dependent on CD44 expression. Cell Immunol 254: 56-62, 2008
44. Nelson PJ, Rees AJ, GriffinMD, Hughes J, Kurts C, Duffield J: The renal mononuclear phagocytic system. J AmSocNephrol 23: 194-203, 2012
45. Ricardo SD, van Goor H, Eddy AA:Macrophage diversity in renal injury and repair. J Clin Invest 118: 3522-3530, 2008
46. Shaul ME, Bennett G, Strissel KJ, Greenberg AS, Obin MS: Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet-induced obesity in mice. Diabetes 59: 1171-1181, 2010
47. Liao X, Sharma N, Kapadia F, Zhou G, Lu Y, Hong H, Paruchuri K, MahabeleshwarGH,Dalmas E, VenteclefN, FlaskCA, KimJ,Doreian BW, Lu KQ, Kaestner KH, Hamik A, Clément K, Jain MK: Krüppel-like factor 4 regulates macrophage polarization. J Clin Invest 121: 2736-2749, 2011
48. Ruffell D,Mourkioti F,Gambardella A, Kirstetter P, Lopez RG, Rosenthal N, Nerlov C: A CREB-C/EBPbeta cascade induces M2 macrophagespecific gene expression and promotes muscle injury repair. Proc Natl Acad Sci U S A 106: 17475-17480, 2009
49. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG: Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29: 13435-13444, 2009
50. Ma LJ, Corsa BA, Zhou J, Yang H, Li H, Tang YW, Babaev VR,Major AS, Linton MF, Fazio S, Hunley TE, Kon V, Fogo AB: Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity. Am J Physiol Renal Physiol 300: F1203-F1213, 2011
51. Lan HY: Role of macrophage migration inhibition factor in kidney disease. Nephron, Exp Nephrol 109: e79-e83, 2008
52. Kang HS, Liao G, DeGraff LM, Gerrish K, Bortner CD, Garantziotis S, JettenAM:CD44 plays a critical role in regulating diet-induced adipose inflammation, hepatic steatosis, and insulin resistance. PLoS One 8: e58417, 2013
53. Yasui T, Okada A, Urabe Y, Usami M, Mizuno K, Kubota Y, Tozawa K, Sasaki S, Higashi Y, Sato Y, KuboM, Nakamura Y,Matsuda K, Kohri K: A replication study for three nephrolithiasis loci at 5q35.3, 7p14.3 and 13q14.1 in the Japanese population. J Hum Genet 58: 588-593, 2013
54. Fujii Y, Okada A, Yasui T, Niimi K, Hamamoto S, Hirose M, Kubota Y, Tozawa K, Hayashi Y, Kohri K: Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis. PLoS One 8: e61343, 2013
55. Honda K, Yoshimura M, Rao TN, Fujishima A: Electrogenerated chemiluminescence of the ruthenium Tris(2,29)bipyridyl/amines system on a boron-doped diamond electrode. J PhysChemB107: 1653-1663, 2003
56. Umeda S, Takahashi K, Shultz LD, Naito M, Takagi K: Effects of macrophage colony-stimulating factor on macrophages and their related cell populations in the osteopetrosis mouse defective in production of functional macrophage colony-stimulating factor protein. Am J Pathol 149: 559-574, 1996
57. Lari R, Fleetwood AJ, Kitchener PD, Cook AD, Pavasovic D, Hertzog PJ, Hamilton JA:Macrophage lineage phenotypes and osteoclastogenesis -complexity in the control by GM-CSF and TGF-beta. Bone 40: 323-336, 2007
58. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD: Granulocytemacrophage colony-stimulating factor (CSF) and macrophage CSFdependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: Implications for CSF blockade in inflammation. J Immunol 178: 5245-5252, 2007
59. Hamers AA, Vos M, Rassam F, Marinkovic G, Kurakula K, van Gorp PJ, de Winther MP, Gijbels MJ, de Waard V, de Vries CJ: Bone marrowspecific deficiency of nuclear receptor Nur77 enhances atherosclerosis. Circ Res 110: 428-438, 2012
60. Zheng D, Wang Y, Cao Q, Lee VW, Zheng G, Sun Y, Tan TK, Wang Y, Alexander SI, Harris DC: Transfused macrophages ameliorate pancreatic and renal injury in murine diabetes mellitus.Nephron, ExpNephrol 118: e87-e99, 2011
61. Oh DY, Morinaga H, Talukdar S, Bae EJ, Olefsky JM: Increased macrophage migration into adipose tissue in obese mice. Diabetes 61: 346-354, 2012
62. Chaiyarit S, Thongboonkerd V: Changes in mitochondrial proteome of renal tubular cells induced by calcium oxalate monohydrate crystal adhesion and internalization are related tomitochondrial dysfunction. J Proteome Res 11: 3269-3280, 2012
63. Li H, Liu Y, ZhangQ, Jing Y, Chen S, Song Z, Yan J, Li Y,Wu X, Zhang X, Zhang Y, Case J, Yu M, Ingram DA, Yang FC: Ras dependent paracrine secretion of osteopontin by Nf1+/- osteoblasts promote osteoclast activation in a neurofibromatosis type I murine model. Pediatr Res 65: 613-618, 2009
64. Kawada M, Seno H, Kanda K, Nakanishi Y, Akitake R, Komekado H, Kawada K, Sakai Y, Mizoguchi E, Chiba T: Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer. Oncogene 31: 3111-3123, 2012
65. Raheja LF, Genetos DC, Yellowley CE: Hypoxic osteocytes recruit human MSCs through an OPN/CD44-mediated pathway. Biochem Biophys Res Commun 366: 1061-1066, 2008
66. Pizzolato P: Histochemical recognition of calcium oxalate. J Histochem Cytochem 12: 333-336, 1964